This unprecedented approach integrates genomic, proteomic, and clonotypic assessment of subclonal multiple myeloma and its precursor stages Late-breaking data on clonal tracking in smoldering to active myeloma progression presented at the European Hematology Association (EHA) show on June 14 ​​SOUTH SAN FRANCISCO, Calif. -- Mission Bio, a leader in single-cell multi-omics solutions for precision medicine, [...]

Quebec City, Canada – Saguaro Biosciences, a pioneering developer of live cell reagents for AI-enhanced discoveries, today announced the successful closing of a $3 million seed funding round, comprised of equity investments and non-dilutive grant funding. The funding round was led by AQC Capital and Anges Québec, featuring significant contributions from notable figures including Martin [...]

Siren Biotechnology to receive products, technologies and contract testing services to develop gene therapy treatments for cancer Experts from MilliporeSigma’s Emprove® team and M Lab™ Collaboration Center to provide consultation and training Company has awarded grants to 40-plus biotechnology companies since 2014 BURLINGTON, Mass. -- MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, [...]

Providing rights to academic research globally aimed at enabling solutions to   complex challenges and driving sustainability in food and agriculture Expanding the potential of CRISPR-based technologies through the collaborative innovation platform Shoots by Syngenta Syngenta Group, one of the world’s largest agricultural technology companies, will provide rights to selected genome-editing and breeding technologies for [...]

HYDERABAD, India -- AmpleLogic, a leading provider of GAMP solutions, announces the launch of its revolutionary Application Platform as a Service (aPaaS) designed specifically for the life sciences sector. This cutting-edge platform leverages low-code/no-code technology to accelerate digitization in life sciences industry while enhancing operational efficiency and ensuring compliance with regulatory standards from USFDA, MHRA, EMEA, ISO, and [...]

ZYMO RESEARCH UNVEILS PUREREC DSN: THE MOST SELECTIVE DUPLEX-SPECIFIC NUCLEASE IRVINE, Calif. — Zymo Research, a leader in biotechnological advancement has launched a new nuclease called PureRec Duplex-Specific Nuclease (DSN) that selectively digests double stranded DNA (dsDNA). This new PureRec DSN promises unparalleled specificity in targeting duplex DNA, unlocking a variety of potential applications. DSN selectively digests dsDNA [...]

WILMINGTON, Del. -- LabWare, a global leader in Laboratory Information Management Systems (LIMS) within the Pharma and BioPharma industry, last month played a key role in spearheading and guiding an exploratory delegation led by the Governor of Delaware to investigate and exchange opportunities within Ireland's BioPharma sector. This visit focused on Ireland's success in biopharmaceutical manufacturing, fostering collaborations, exploring innovation, and leveraging valuable insights [...]

New tools will advance study—and hopefully treatment—of common genetic heart conditions. For every 500 people reading this, one likely has a disease called hypertrophic cardiomyopathy (HCM). It is the most common genetic heart condition in the world, primarily caused by mutations that thicken heart muscle and, in rare cases, lead to heart failure and cardiac [...]

QUEBEC CITY -- Saguaro Biosciences, a pioneering developer of live cell reagents for AI-enhanced discoveries, today announced the successful closing of a $3 million seed funding round, comprised of equity investments and non-dilutive grant funding. The funding round was led by AQC Capital and Anges Québec, featuring significant contributions from notable figures including Martin Leblanc, [...]

GMP-compliant 50L and 250L SUPRs support large-scale recombinant antibody production Morgan Hill, USA and Delft, Netherlands: Aragen Bioscience, a leading Contract Research Development and Manufacturing Organization (CRDMO) for small molecules and biologics, and Getinge, a Swedish life sciences products and solutions provider, today announced the successful validation of latter’s Single-Use Production Reactors (SUPR) for large-scale recombinant [...]